JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257575

Human PBK (SPK) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

PBK KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2.

View Alternative Names

CT84, Cancer/testis antigen 84, Epididymis luminal protein 164, FLJ14385, HEL164, Lymphokine-activated killer T-cell-originated protein kinase, MAPKK-like protein kinase, Nori-3, PBK, PDZ-binding kinase, SPK, Serine/threonine protein kinase, Spermatogenesis-related protein kinase, T-LAK cell-originated protein kinase, TOPK_HUMAN

3 Images
Western blot - Human PBK (SPK) knockout HEK-293T cell lysate (AB257575)
  • WB

Lab

Western blot - Human PBK (SPK) knockout HEK-293T cell lysate (AB257575)

Lane 1 : Wild-type HEK-293T cell lysate (20µg)

Lane 2 : PBK knockout HEK-293T cell lysate (20µg)

Lanes 1- 2 : Merged signal (red and green). Green - ab75987 observed at 40 kDa. Red - loading control ab7291 observed at 50 kDa.

ab75987 Anti-PBK/SPK antibody [EP2520Y] was shown to specifically react with PBK/SPK in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266827 (knockout cell lysate ab257575) was used. Wild-type and PBK/SPK knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab75987 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 100000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PBK/SPK antibody [EP2520Y] (<a href='/en-us/products/primary-antibodies/pbk-spk-antibody-ep2520y-ab75987'>ab75987</a>) at 1/100000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

PBK knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human PBK (SPK) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-pbk-spk-knockout-hek-293t-cell-line-ab266827'>ab266827</a>)

Predicted band size: 27 kDa,36 kDa

Observed band size: 40 kDa

false

Western blot - Human PBK (SPK) knockout HEK-293T cell lysate (AB257575)
  • WB

Lab

Western blot - Human PBK (SPK) knockout HEK-293T cell lysate (AB257575)

Lane 1 : Wild-type HEK-293T cell lysate (20µg)

Lane 2 : PBK knockout HEK-293T cell lysate (20µg)

Lanes 1- 2 : Merged signal (red and green). Green - ab236871 observed at 40 kDa. Red - loading control ab7291 observed at 50 kDa.

ab236871 Anti-PBK/SPK antibody [EPR21982] was shown to specifically react with PBK/SPK in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266827 (knockout cell lysate ab257575) was used. Wild-type and PBK/SPK knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab236871 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PBK/SPK antibody [EPR21982] (<a href='/en-us/products/primary-antibodies/pbk-spk-antibody-epr21982-ab236871'>ab236871</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

PBK knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human PBK (SPK) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-pbk-spk-knockout-hek-293t-cell-line-ab266827'>ab266827</a>)

Predicted band size: 36 kDa

Observed band size: 40 kDa

false

Sanger Sequencing - Human PBK (SPK) knockout HEK-293T cell lysate (AB257575)
  • Sanger seq

Unknown

Sanger Sequencing - Human PBK (SPK) knockout HEK-293T cell lysate (AB257575)

Homozygous : 1 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257575-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PBK knockout HEK293T cell lysate", "number":"AB257575-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB257575-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
PBK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PBK/SPK also known as PDZ-binding kinase or Cdc2-related kinase is a serine/threonine protein kinase with an approximate molecular weight of 47 kDa. This protein is involved in cell division playing an important role in mitotic processes. PBK/SPK is expressed in various tissues including significant levels in testis and placenta often in proliferating cell types. It also exhibits higher expression in cancerous tissues suggesting a role in tumorigenesis.
Biological function summary

PBK/SPK facilitates cell cycle progression and cellular proliferation. This protein is not typically part of larger complexes but it partners with other molecules during cell division to ensure proper mitotic spindle formation and chromosome segregation. Its expression levels increase during the G2/M phase of the cell cycle indicating its involvement in cell cycle regulation. In cancer it often shows overexpression contributing to unregulated proliferation of cancer cells.

Pathways

PBK/SPK is associated with critical cell division pathways such as the MAPK signaling pathway. This involvement impacts cellular responses to growth signals and stress. PBK can phosphorylate and interact with proteins like p38 MAPK which further modulates signal transduction related to cellular growth and survival. Through these pathways PBK/SPK helps manage the balance between cell division and apoptosis particularly under stress conditions.

PBK/SPK has strong correlations with cancer especially glioblastoma and cervical cancer. Overexpression of PBK often links to poor prognosis in these conditions. In cancerous settings PBK interacts with proteins such as p53 and c-Myc influencing tumor progression and resistance to therapy. PBK can modulate oncogenic pathways providing a potential target for therapeutic intervention in tumor proliferation and survival.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com